Cancer Patients Cumulatively Saved Around Rs 294 Crore Due To Price Control: JP Nadda

New Delhi: The government makes all efforts to ensure affordable and accessible treatment is available for cancer patients amid a rise in cases in India, Health Minister JP Nadda said on Friday.

Replying to supplementary questions during Question Hour in the Lok Sabha, Nadda said the government made all efforts to ensure that affordable and accessible treatment was available to the patients.

“The number of cancer cases is going up, it is increasing by almost 2.5 per cent every year,” Nadda said.

In men, cases of oral and lung cancer are on the up while more women are getting breast cancer, he added.

More than 1.55 million cancer cases are being registered every year, Nadda said.

“There is a list of 131 essential cancer medicines, which are in Schedule 1, (that) are monitored and (their) pricing is decided by the government. These are the commonly used medicines,” Nadda said.

He said patients cumulatively saved around Rs 294 crore due to this price control.

“There are 28 combinations, which are not in this list but the NPPA (National Pharmaceutical Pricing Authority) and the government have controlled their pricing as well,” he said.

“We have tried to make cancer drugs affordable,” he added.

Responding to another question on healthcare infrastructure, Nadda said the government was apprised of the matter and expansion of medical colleges were happening so that there could be more doctors.

“There should be a balance in quality and quantity of medical education. We are trying to go as fast as we can but, at the same time, (we) do not want to compromise on the quality of medical doctors,” he said.

Nadda informed the House that the number of medical colleges had gone up from 387 in 2014 to 731 at present while the number of MBBS seats rose from 51,348 seats to 1,12,112 (1.12 lakh) during the same period.

The number of postgraduate seats for medical students has gone up from 31,185 in 2014 to 72,627 at present, he added.

Related Posts

  • Pharma
  • October 18, 2024
  • 19 views
Fake Blood Unit Sold To Patient For Rs 7,000 At UP Medical College, FIR Registered

Hardoi:  A shocking case of illegal blood trade has come to light at the Hardoi Medical College in Uttar Pradesh, raising serious concerns about patient safety and the integrity of…

  • Pharma
  • October 17, 2024
  • 121 views
CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

Thiruvananthapuram:  The Centre of Excellence in Ayurveda Research to be established on the campus of the CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) at Pappanamcode here is envisaged as…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fake Blood Unit Sold To Patient For Rs 7,000 At UP Medical College, FIR Registered

Fake Blood Unit Sold To Patient For Rs 7,000 At UP Medical College, FIR Registered

CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

Health Worker Arrested For Mixing TB Patient’s Sputum In Doctor’s Food

Health Worker Arrested For Mixing TB Patient’s Sputum In Doctor’s Food

Cipla, Alkem Eye Rs 4,000 Crore Stake In India’s Largest Stent Manufacturer

Cipla, Alkem Eye Rs 4,000 Crore Stake In India’s Largest Stent Manufacturer

DTAB Recommends To Do Away With Toxicity Studies For Intravenous Infusions And Injectables

DTAB Recommends To Do Away With Toxicity Studies For Intravenous Infusions And Injectables